1 / 31

The Spleen

The Spleen. Lecture Conference Steven J. Binenbaum, MD SLR September 12 th , 2007. Splenectomy for Hematologic Diseases. Rarely cures the disease Alleviates symptoms Corrects hematologic abnormalities Staging & Diagnosis. Splenectomy for Hematologic Diseases.

Jims
Download Presentation

The Spleen

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Spleen Lecture Conference Steven J. Binenbaum, MD SLR September 12th, 2007

  2. Splenectomy for Hematologic Diseases • Rarely cures the disease • Alleviates symptoms • Corrects hematologic abnormalities • Staging & Diagnosis

  3. Splenectomy for Hematologic Diseases Red Cell-Related Indications Hereditary Spherocytosis (HS) • Most common type of hemolytic anemia • Autosomal dominant • Spectrin deficiency (RBC membrane) → Loss of osmotic stability • Osmotic fragility testing • Splenomegaly & Gall stones • Dx by (+) spherocytes in the blood • TOC is Splenectomy in the 4th year of life • +/- cholecystectomy if (+) cholelithiasis

  4. Splenectomy for Hematologic Diseases Autoimmune Hemolytic Anemia (AIHA) • Warm-antibody autoimmune HA • Autoantibody opsonization and phagocytosis • Intravascular destruction or by spleen macrophages • Treatment Of Choice • #1 is Corticosteroids 1-2 mg/kg/day • PRBC’s for severe anemia • Splenectomy (80% favorable clinical response) if: • medical tx fails • Intolerance to steroids or its side-effects

  5. Splenectomy for Hematologic Diseases Pyruvate kinase Deficiency • Autosomal-recessive disease • Splenomegaly • TOC • Splenectomy • Reduces PRBC’s requirements G6PD Deficiency • Splenomegaly is rare • Splenectomy is not indicated!

  6. Splenectomy for Hematologic Diseases Sickle Cell Disease (SCD) • B-globin gene A→T substitution (Hb S/SS) • autosomal dominant • Sickling of RBCs in tissues with low O2 tension • Red & White pulps • Splenic microinfarcts • Painful • Abscess • Infections • Anemia • Splenectomy (palliative) • Acute sequestration crises (recurrence = 40%-50% with 20% Mortality rate) • Rapid hypersplenism • Abscess formation

  7. Splenectomy for Hematologic Diseases Thalassemia • Thalassemia major (homozygous B) • autosomal-dominant disease • Decreased expression of beta-chains • Pallor, Growth retardation, head enlargement • Splenectomy indicated if: • Symptomatic splenomegaly • Anemia • Pain due to infarctions • increased PRBC’s requirements (>200 ml/kg/year) • ↑ rate of infections after splenectomy • Risk vs. Benefit

  8. ITP Spleen is not enlarged ♀ > ♂; Renal insufficiency children vs. adults Self-limited in children (70%) Splenectomy is for rare cases Insidious onset in adults ↓ Plts < 10,000/mm3 #1 TOC is PO Steroids 1-1.5 mg/kg/d (up to 70% response) IVIG 1 g/kg/d x2-3 days Splenectomy if fail steroid tx TTP Splenomegaly Microvascular thrombosis Petechiae, fever, neurologic changes #1 TOC Plasmaphoresis Splenectomy is #2 Durable remission? Avoid PLT transfusions ↑ morbidity Splenectomy for Hematologic DiseasesPlatelet Related Indications

  9. White Cell - Related Indications Leukemia • CLL & Hairy cell leukemia (HCL) • Splenectomy • improves cytopenias (75%) • Ameliorates symptomatic splenomegaly Non-Hodgkin’s Lymphoma (NHL) • Splenectomy • Painful splenomegaly • Cytopenia • No role for staging

  10. White Cell - Related Indications Hodgkin’s Disease • Current indications for surgical staging: • Stage I or Stage II with NS histology and w/o B-symptoms • Staging procedure • Wedge liver biopsy • LN sampling: • Retroperitoneal • Mesenteric • Hepatoduodenal • Splenectomy

  11. Bone Marrow – Related Indications • Myelofibrosis & Myeloproliferative disorders • Splenectomy for symptoms due to enlarged spleen

  12. Splenectomy Complications • LLL atelectasis, pneumonia, effusion • Hemorrhage (mostly with laparoscopic) • Intraabdominal abscess (LUQ) • Pancreatitis or fistula formation • DVT • PVT • Hemolytic anemia or myeloproliferative dz with splenomegaly • OPSI

  13. Splenectomy Complications OPSI • Incidence ≈1% (up to 5%); 50% Mortality • Encapsulated gram-positive bacteria = Streptococcus • Risk factors • Children < 15 yrs old • Immunosupression • Hematologic dz (thalassemia, SCD, etc) • Highest within the first 2 yrs post splenectomy • Pnemococcus, H.influenza, meningococcus • vaccination 7-14 days prior to splenectomy • Pneumovax booster Q5yrs and annual H.influenza immunizations • Abx prophylaxis for children x2 yrs post splenectomy • Lower incidence of OPSI in adults (vs children) and after trauma

  14. Tumors, Cysts, and Abscesses of the Spleen Steven J. Binenbaum, MD September 12th, 2007 SLR

  15. Malignant Tumors • Spleen - mostly secondary involvement • non-Hodgkin’s Lymphoma – most common malignancy • Main Tx: Chemo +/- RT • Spleen is the primary site • 10% Hodgkin’s disease • 30% of resected spleens (staging procedure) have (+) histology • Hairy cell leukemia • Resect for symptomatic splenomegaly • Improved survival • CML & CLL • symptomatic splenomegaly = splenectomy

  16. Malignant Tumors • Angiosarcoma • Nonlymphoid malignant tumor of the spleen • Early metastatic disease • Aggressive with rapid growth • Spontaneous splenic rupture and hemolytic anemia • Palliation Benign Tumors • Hemangioma • Risk of rupture + platelet sequestration (Syndrome?) • No tx unless symptomatic • Hamartoma • Lymphangioma

  17. Nonparasitic Epithelium-lined cysts Epidermoid cysts – most common Mostly asymptomatic Young children + young adults LUQ pain, N/V, early satiety Dx: CTscan (+)unilocular +/- Ca++ Complications Infection, bleeding, rupture Tx: Splenectomy partial Parasitic 5% in US Abroad – Hydatid disease Echinococcus granulosus Mostly asymptomatic Associated with liver cysts If only spleen is involved? Tx: Splenectomy Splenic Cysts

  18. Splenic Cysts • Splenic Pseudocysts • Lack epithelial lining • Account for most cystic splenic dz in US • Pancreatic pseudocyst • Posttraumatic • Splenectomy is indicated when: • Size >10 cm or • symptomatic

  19. Splenic Abscess • Uncommon, but fatal • Erode into adjacent structures • Most are secondary in etiology • Bacterial endocarditis • Intrabdominal infections (pyelo-, etc) • IVDA • Infected splenic hematoma • Infected splenic infarctions (embolizations, ischemia, etc) • S/S: fever, WBC; • 50% (+) blood cultures • Dx by CT scan + IV contrast • Staphylococcus & Streptococcus • E.coli, Salmonella, anaerobes • Tx: • Splenectomy + IV Abx • Percutaneous drainage

  20. Splenic Salvage Procedures: Therapeutic Options SLR September 12th, 2007

  21. Nonoperative Management of Splenic Trauma Indications for initial nonoperative management • hemodynamic stability • absence of peritonitis • CT scan • No contrast extravasation • absence of other injuries • Transfusions - >2 PRBC’s

  22. Protocol for Nonoperative Management Grade I & II • Awake + alert, isolated injury • monitored observation • BR, H/H q6h, serial abdominal exams • Regular floor in 48º • If remain stable and asymptomatic – D/C in 5 days • F/U CT scan in 4 wks • Avoid prophylactic and therapeutic heparinization • Grade III, IV, & V • Monitored observation x5 days • Repeat CT scan • Transfer to floor if stable • F/U CT scan in 6-8 wks after discharge

  23. Splenorrhaphy • Topical Hemostasis • Small injuries (I & II) • Bovie electrocautery • Argon beam • Gelfoam • Surgicel • Avitene • Suture Repair & Partial Resection • Segmental blood supply • Monofilament sutures • Pledgeted horizontal mattress sutures

  24. Splenorrhaphy • Mesh Splenorrhaphy • Delaney (1982) • Autotransplantation • controversial

More Related